{"id":{"repo_id":"cuny","oai_identifier":"oai:academicworks.cuny.edu:cc_etds_theses-2413"},"canonical_url":"https://search.dev.ndltd.org/etd/cuny/oai:academicworks.cuny.edu:cc_etds_theses-2413","repository":{"repo_id":"cuny","name":"City University of New York - City College","base_url":"https://academicworks.cuny.edu/do/oai/"},"display":{"title":"Defining the role of heparan sulfate proteoglycans in APL-1 function in Caenorhabditis elegans","abstract":"<p>Alzheimer’s Disease (AD) is a neurodegenerative disease that affects more than 7.2 million adults in the U.S. AD is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. The b-amyloid peptide is the major component of the plaques and is produced as a cleavage byproduct of the amyloid precursor protein (APP). APP family proteins are present in mammals and the family is considered necessary and essential for viability, although their exact function is still unclear. In <em>Caenorhabditis elegans</em> only one ortholog of <em>APP</em> is present, <em>apl-1</em>. Similar to <em>APP</em> family members, <em>apl-1</em> is essential for viability; APL-1 is cleaved and releases an extracellular fragment, sAPL-1, into the extracellular matrix (ECM). Based on previous research in the lab, sAPL-1 likely interacts with ECM proteins to guide sAPL-1 to its target receptors. Heparin sulfate proteoglycans (HSPGs), such as LON-2 glypican and UNC-52 perlecan, are likely candidates for the ECM proteins that interact and guide sAPL-1. The disruption of APL-1 causes phenotypical changes, including in learning, reproduction, and memory; these defects are enhanced when HSPG activities are decreased. We also examined how loss of HSPG function affects sAPL-1 clearance. These results suggest that these two proteins play an active role in APL-1 function. Furthermore, we expanded previous research and found that loss of a candidate suppressor gene, GLuCuronosylTransferase-like 6 (<em>glct-6) </em>which encodes for galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase, does not have suppress the <em>apl-1(yn10)</em> lethality. This research helps provide a framework and direction that could help in further understanding both <em>apl-1</em> function in <em>C. elegans</em> and the relationship of HSPGs and APP clearance in humans.</p>","abstract_html":"&lt;p&gt;Alzheimer’s Disease (AD) is a neurodegenerative disease that affects more than 7.2 million adults in the U.S. AD is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. The b-amyloid peptide is the major component of the plaques and is produced as a cleavage byproduct of the amyloid precursor protein (APP). APP family proteins are present in mammals and the family is considered necessary and essential for viability, although their exact function is still unclear. In &lt;em&gt;Caenorhabditis elegans&lt;/em&gt; only one ortholog of &lt;em&gt;APP&lt;/em&gt; is present, &lt;em&gt;apl-1&lt;/em&gt;. Similar to &lt;em&gt;APP&lt;/em&gt; family members, &lt;em&gt;apl-1&lt;/em&gt; is essential for viability; APL-1 is cleaved and releases an extracellular fragment, sAPL-1, into the extracellular matrix (ECM). Based on previous research in the lab, sAPL-1 likely interacts with ECM proteins to guide sAPL-1 to its target receptors. Heparin sulfate proteoglycans (HSPGs), such as LON-2 glypican and UNC-52 perlecan, are likely candidates for the ECM proteins that interact and guide sAPL-1. The disruption of APL-1 causes phenotypical changes, including in learning, reproduction, and memory; these defects are enhanced when HSPG activities are decreased. We also examined how loss of HSPG function affects sAPL-1 clearance. These results suggest that these two proteins play an active role in APL-1 function. Furthermore, we expanded previous research and found that loss of a candidate suppressor gene, GLuCuronosylTransferase-like 6 (&lt;em&gt;glct-6) &lt;/em&gt;which encodes for galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase, does not have suppress the &lt;em&gt;apl-1(yn10)&lt;/em&gt; lethality. This research helps provide a framework and direction that could help in further understanding both &lt;em&gt;apl-1&lt;/em&gt; function in &lt;em&gt;C. elegans&lt;/em&gt; and the relationship of HSPGs and APP clearance in humans.&lt;/p&gt;","abstract_has_math":false,"creators":["Au, Rebecca"],"institution":null,"degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":["Christine Li"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026-01-01T08:00:00Z","date_published":"2026-01-01T08:00:00Z","updated_at":"2026-07-24T01:58:13Z","subjects":["APP family","APL-1","Alzheimer’s Disease","Heparan Sulfate Proteoglycans (HSPGs)","Amyloid Precursor-Like","Developmental Neuroscience","Genetics","Molecular and Cellular Neuroscience","Molecular Genetics"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://academicworks.cuny.edu/cc_etds_theses/1308","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Christine Li"]},{"key":"dc:creator","label":"Author","values":["Au, Rebecca"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2027-05-12T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["APP family","APL-1","Alzheimer’s Disease","Heparan Sulfate Proteoglycans (HSPGs)","Amyloid Precursor-Like","Developmental Neuroscience","Genetics","Molecular and Cellular Neuroscience","Molecular Genetics"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://academicworks.cuny.edu/cc_etds_theses/1308"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Alzheimer’s Disease (AD) is a neurodegenerative disease that affects more than 7.2 million adults in the U.S. AD is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. The b-amyloid peptide is the major component of the plaques and is produced as a cleavage byproduct of the amyloid precursor protein (APP). APP family proteins are present in mammals and the family is considered necessary and essential for viability, although their exact function is still unclear. In <em>Caenorhabditis elegans</em> only one ortholog of <em>APP</em> is present, <em>apl-1</em>. Similar to <em>APP</em> family members, <em>apl-1</em> is essential for viability; APL-1 is cleaved and releases an extracellular fragment, sAPL-1, into the extracellular matrix (ECM). Based on previous research in the lab, sAPL-1 likely interacts with ECM proteins to guide sAPL-1 to its target receptors. Heparin sulfate proteoglycans (HSPGs), such as LON-2 glypican and UNC-52 perlecan, are likely candidates for the ECM proteins that interact and guide sAPL-1. The disruption of APL-1 causes phenotypical changes, including in learning, reproduction, and memory; these defects are enhanced when HSPG activities are decreased. We also examined how loss of HSPG function affects sAPL-1 clearance. These results suggest that these two proteins play an active role in APL-1 function. Furthermore, we expanded previous research and found that loss of a candidate suppressor gene, GLuCuronosylTransferase-like 6 (<em>glct-6) </em>which encodes for galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase, does not have suppress the <em>apl-1(yn10)</em> lethality. This research helps provide a framework and direction that could help in further understanding both <em>apl-1</em> function in <em>C. elegans</em> and the relationship of HSPGs and APP clearance in humans.</p>"]},{"key":"dc:title","label":"Title","values":["Defining the role of heparan sulfate proteoglycans in APL-1 function in Caenorhabditis elegans"]}]}],"canonical_facts":{"dc:contributor":["Christine Li"],"dc:creator":["Au, Rebecca"],"dc:date.available":["2027-05-12T07:00:00Z"],"dc:description.abstract":["<p>Alzheimer’s Disease (AD) is a neurodegenerative disease that affects more than 7.2 million adults in the U.S. AD is characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. The b-amyloid peptide is the major component of the plaques and is produced as a cleavage byproduct of the amyloid precursor protein (APP). APP family proteins are present in mammals and the family is considered necessary and essential for viability, although their exact function is still unclear. In <em>Caenorhabditis elegans</em> only one ortholog of <em>APP</em> is present, <em>apl-1</em>. Similar to <em>APP</em> family members, <em>apl-1</em> is essential for viability; APL-1 is cleaved and releases an extracellular fragment, sAPL-1, into the extracellular matrix (ECM). Based on previous research in the lab, sAPL-1 likely interacts with ECM proteins to guide sAPL-1 to its target receptors. Heparin sulfate proteoglycans (HSPGs), such as LON-2 glypican and UNC-52 perlecan, are likely candidates for the ECM proteins that interact and guide sAPL-1. The disruption of APL-1 causes phenotypical changes, including in learning, reproduction, and memory; these defects are enhanced when HSPG activities are decreased. We also examined how loss of HSPG function affects sAPL-1 clearance. These results suggest that these two proteins play an active role in APL-1 function. Furthermore, we expanded previous research and found that loss of a candidate suppressor gene, GLuCuronosylTransferase-like 6 (<em>glct-6) </em>which encodes for galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase, does not have suppress the <em>apl-1(yn10)</em> lethality. This research helps provide a framework and direction that could help in further understanding both <em>apl-1</em> function in <em>C. elegans</em> and the relationship of HSPGs and APP clearance in humans.</p>"],"dc:identifier":["https://academicworks.cuny.edu/cc_etds_theses/1308"],"dc:subject":["APP family","APL-1","Alzheimer’s Disease","Heparan Sulfate Proteoglycans (HSPGs)","Amyloid Precursor-Like","Developmental Neuroscience","Genetics","Molecular and Cellular Neuroscience","Molecular Genetics"],"dc:title":["Defining the role of heparan sulfate proteoglycans in APL-1 function in Caenorhabditis elegans"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (M.S.)"]},"updated_at":"2026-07-24T01:58:13Z"}